摘要
本文选择小鼠T淋巴细胞系(YAC-I)为基因转移的靶细胞,采用Lipofectin介导的基因转移方法,将载有人腺苷脱氨酶(ADA)基因的真核表达载体和载有Neo^R基因的真核表达载体共转化导入体外培养的YAC-I细胞,然后对转化筛选后的YAC-I细胞进行了ADA的定性定量分析。实验结果表明:经转化筛选的YAC-I细胞中的ADA活性为未转化YAC-I细胞中内源ADA活性的l.6倍,且转化筛选的YAC-I可经电泳分离出两条迁移率不同的人、鼠ADA同工酶带,提示Lipofectin介导转移的外源性人ADA基因在小鼠淋巴细胞中获得了表达,从而为以后开展基因治疗研究提供了一定的实验依据。
In this report,Murine T-Lymphocytes have been chosen as target cells for lipofectin mediated gene transfer.Eukaryotic expression vectors which carry human ADA gene and Neo^R gene respectively have been transfected into the cultured Yac-I cells by cotransfection .After selection with G418,quantitative and qualitative assays of transfected Yac-I cells were conducted.The results showed that ADA activity in transfected cells is 1.6:times higher han non-transfected cells,and two isozyme bands of human and murine ADA with different migration rates were separated from transfected and G418-selected YacI cells on acetate cellulose electrophoresis.Our results suggest that exogenous human ADA gene were expressed efficiently in murine cells.It could provide a experimental basis for further gene therapy research.
出处
《华中科技大学学报(医学版)》
CAS
CSCD
北大核心
1994年第S2期89-91,共3页
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金
卫生部青年科学基金
关键词
腺苷脱氨酶
基因转移
基因表达
基因治疗
Adenosine deaminase,Gene transfer,Gene expression,gene therapy